PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data

BACKGROUND: Large-sequencing cancer genome projects have shown that tumors have thousands of molecular alterations and their frequency is highly heterogeneous. In such scenarios, physicians and oncologists routinely face lists of cancer genomic alterations where only a minority of them are relevant...

Descripción completa

Detalles Bibliográficos
Autores principales: Piñeiro-Yáñez, Elena, Reboiro-Jato, Miguel, Gómez-López, Gonzalo, Perales-Patón, Javier, Troulé, Kevin, Rodríguez, José Manuel, Tejero, Héctor, Shimamura, Takeshi, López-Casas, Pedro Pablo, Carretero, Julián, Valencia, Alfonso, Hidalgo, Manuel, Glez-Peña, Daniel, Al-Shahrour, Fátima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Software
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977747/
https://www.ncbi.nlm.nih.gov/pubmed/29848362
http://dx.doi.org/10.1186/s13073-018-0546-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977747/
https://www.ncbi.nlm.nih.gov/pubmed/29848362
http://dx.doi.org/10.1186/s13073-018-0546-1

Ejemplares similares